Literature DB >> 3886923

Heel pad thickness: determination by high-resolution ultrasonography.

G A Gooding, R M Stress, P M Graf, C Grunfeld.   

Abstract

Heel pad thickness classically is increased in acromegaly and can also be noted in long-term Dilantin therapy. A high-resolution 10-MHz dedicated superficial small parts real-time scanner was used to evaluate heel pad thickness without the use of radiation and without the magnification inherent in the standard procedure, a lateral radiograph of the foot. Fifty-four patients were studied, and it was determined in 10 controls that heel pad thickness averaged 16.6 mm. In 38 diabetics without ulcers of the feet, the heel pad was 17.8 mm. A single treated acromegalic had a heel pad thickness of 21 mm. Ultrasonography offers an effective alternative to radiography in the measurement of heel pad thickness.

Entities:  

Mesh:

Year:  1985        PMID: 3886923     DOI: 10.7863/jum.1985.4.4.173

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  4 in total

1.  Dynamics of longitudinal arch support in relation to walking speed: contribution of the plantar aponeurosis.

Authors:  Paolo Caravaggi; Todd Pataky; Michael Günther; Russell Savage; Robin Crompton
Journal:  J Anat       Date:  2010-07-14       Impact factor: 2.610

2.  Sonography of the nonossified tarsal navicular cartilage in an infant with congenital vertical talus.

Authors:  A E Schlesinger; V F Deeney; P F Caskey
Journal:  Pediatr Radiol       Date:  1989

3.  Three-dimensional morphology of heel fat pad: an in vivo computed tomography study.

Authors:  Valentina Campanelli; Massimiliano Fantini; Niccolò Faccioli; Alessio Cangemi; Antonio Pozzo; Andrea Sbarbati
Journal:  J Anat       Date:  2011-08-17       Impact factor: 2.610

4.  Can ultrasound measures of intrinsic foot muscles and plantar soft tissues predict future diabetes-related foot disease? A systematic review.

Authors:  Troy Morrison; Sara Jones; Ryan S Causby; Kerry Thoirs
Journal:  PLoS One       Date:  2018-06-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.